Cargando…
Drug Therapy in Atrial Fibrillation Management: Where Do We Stand in 2010?
Atrial fibrillation (AF) is a commonly encountered arrhythmia in our daily practice. Every year a huge bulk of data is published about different management strategies, new antiarrhythmic drugs, anticoagulation protocols and ablation procedures in these patients. In this review article, we discuss di...
Autores principales: | Davoodi, Gholamreza, Montazeri, Mehdi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3466855/ https://www.ncbi.nlm.nih.gov/pubmed/23074588 |
Ejemplares similares
-
The theranostic promise for Neuroendocrine Tumors in the late 2010s - Where do we stand, where do we go?
por: Werner, Rudolf A., et al.
Publicado: (2018) -
Ablative Management of Persistent Atrial Fibrillation (PeAF) with Posterior Wall Isolation (PWI): Where Do We Stand?
por: Baqal, Omar, et al.
Publicado: (2023) -
Where Do We Stand?
Publicado: (1891) -
Drug Repurposing for the Management of Depression: Where Do We Stand Currently?
por: Mohammad Sadeghi, Hosna, et al.
Publicado: (2021) -
Gene therapy for arthritis – where do we stand?
por: Chernajovsky, Yuti
Publicado: (2005)